CN1562974A - Method for synthesizing 1,2,3,4 ramification of tetrahydro-isoquinoline - Google Patents
Method for synthesizing 1,2,3,4 ramification of tetrahydro-isoquinoline Download PDFInfo
- Publication number
- CN1562974A CN1562974A CN 200410032017 CN200410032017A CN1562974A CN 1562974 A CN1562974 A CN 1562974A CN 200410032017 CN200410032017 CN 200410032017 CN 200410032017 A CN200410032017 A CN 200410032017A CN 1562974 A CN1562974 A CN 1562974A
- Authority
- CN
- China
- Prior art keywords
- reaction
- acid
- butylamine
- synthesizing
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 19
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 title claims description 19
- 230000002194 synthesizing effect Effects 0.000 title claims description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 33
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 20
- -1 di(methoxy) methyl Chemical group 0.000 claims abstract description 15
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 9
- 239000002253 acid Substances 0.000 claims abstract description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 42
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 238000006243 chemical reaction Methods 0.000 claims description 25
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
- 239000001257 hydrogen Substances 0.000 claims description 11
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 10
- 239000007810 chemical reaction solvent Substances 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical group C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 claims description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims description 8
- 239000003054 catalyst Substances 0.000 claims description 7
- 150000007522 mineralic acids Chemical class 0.000 claims description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 claims description 6
- 238000009903 catalytic hydrogenation reaction Methods 0.000 claims description 6
- NKDDWNXOKDWJAK-UHFFFAOYSA-N dimethoxymethane Chemical compound COCOC NKDDWNXOKDWJAK-UHFFFAOYSA-N 0.000 claims description 6
- 150000008282 halocarbons Chemical group 0.000 claims description 6
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 claims description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 5
- PIVJVCRQCUYKNZ-UHFFFAOYSA-N 2-(benzylazaniumyl)-3-phenylpropanoate Chemical compound C=1C=CC=CC=1CNC(C(=O)O)CC1=CC=CC=C1 PIVJVCRQCUYKNZ-UHFFFAOYSA-N 0.000 claims description 5
- 238000005984 hydrogenation reaction Methods 0.000 claims description 5
- 238000007327 hydrogenolysis reaction Methods 0.000 claims description 5
- 150000007524 organic acids Chemical class 0.000 claims description 5
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- ATYZESQWLIYILH-SFHVURJKSA-N (2s)-2-(benzylamino)-n-tert-butyl-3-phenylpropanamide Chemical compound C([C@@H](C(=O)NC(C)(C)C)NCC=1C=CC=CC=1)C1=CC=CC=C1 ATYZESQWLIYILH-SFHVURJKSA-N 0.000 claims description 4
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 4
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical group [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 claims description 4
- 238000005917 acylation reaction Methods 0.000 claims description 4
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 claims description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 4
- 239000012046 mixed solvent Substances 0.000 claims description 4
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 claims description 4
- 229910015900 BF3 Inorganic materials 0.000 claims description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 238000006555 catalytic reaction Methods 0.000 claims description 3
- 150000007529 inorganic bases Chemical class 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 238000007171 acid catalysis Methods 0.000 claims description 2
- 239000003377 acid catalyst Substances 0.000 claims description 2
- 238000010945 base-catalyzed hydrolysis reactiony Methods 0.000 claims description 2
- 239000007809 chemical reaction catalyst Substances 0.000 claims description 2
- 238000006482 condensation reaction Methods 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 235000005985 organic acids Nutrition 0.000 claims description 2
- 235000019260 propionic acid Nutrition 0.000 claims description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 2
- 238000006722 reduction reaction Methods 0.000 claims description 2
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 150000002430 hydrocarbons Chemical group 0.000 claims 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 claims 1
- 239000007868 Raney catalyst Substances 0.000 claims 1
- 229910000564 Raney nickel Inorganic materials 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 229930195733 hydrocarbon Natural products 0.000 claims 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract description 18
- 239000002994 raw material Substances 0.000 abstract description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract description 3
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 abstract description 3
- 150000002148 esters Chemical class 0.000 abstract description 2
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 abstract 1
- 239000003183 carcinogenic agent Substances 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 239000012141 concentrate Substances 0.000 description 12
- 238000003756 stirring Methods 0.000 description 11
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- 239000012044 organic layer Substances 0.000 description 8
- 238000010992 reflux Methods 0.000 description 7
- 238000005160 1H NMR spectroscopy Methods 0.000 description 5
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
- 238000006929 Pictet-Spengler synthesis reaction Methods 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000000711 cancerogenic effect Effects 0.000 description 3
- 229960001701 chloroform Drugs 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 230000006340 racemization Effects 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 231100000315 carcinogenic Toxicity 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- GVTZTBHOYNXMKJ-INIZCTEOSA-N methyl (2s)-2-(benzylamino)-3-phenylpropanoate Chemical compound C([C@@H](C(=O)OC)NCC=1C=CC=CC=1)C1=CC=CC=C1 GVTZTBHOYNXMKJ-INIZCTEOSA-N 0.000 description 2
- LHVBLSYZKOQEFQ-INIZCTEOSA-N methyl (2s)-2-(benzylideneamino)-3-phenylpropanoate Chemical compound C([C@@H](C(=O)OC)N=CC=1C=CC=CC=1)C1=CC=CC=C1 LHVBLSYZKOQEFQ-INIZCTEOSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- GGUKWEDEPRDYOR-HNNXBMFYSA-N (2S)-2-(benzylideneamino)-3-phenylpropanoic acid Chemical compound C(C1=CC=CC=C1)=N[C@@H](CC1=CC=CC=C1)C(=O)O GGUKWEDEPRDYOR-HNNXBMFYSA-N 0.000 description 1
- BWKMGYQJPOAASG-VIFPVBQESA-N (3s)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid Chemical compound C1=CC=C2CN[C@H](C(=O)O)CC2=C1 BWKMGYQJPOAASG-VIFPVBQESA-N 0.000 description 1
- QAGYKUNXZHXKMR-UHFFFAOYSA-N CPD000469186 Natural products CC1=C(O)C=CC=C1C(=O)NC(C(O)CN1C(CC2CCCCC2C1)C(=O)NC(C)(C)C)CSC1=CC=CC=C1 QAGYKUNXZHXKMR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 101100096444 Drosophila melanogaster spin gene Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000002259 anti human immunodeficiency virus agent Substances 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000006264 debenzylation reaction Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- HKYGSMOFSFOEIP-UHFFFAOYSA-N dichloro(dichloromethoxy)methane Chemical compound ClC(Cl)OC(Cl)Cl HKYGSMOFSFOEIP-UHFFFAOYSA-N 0.000 description 1
- PHBAAFDKJNNRNJ-UHFFFAOYSA-N dimethoxymethoxy(dimethoxy)methane Chemical compound COC(OC)OC(OC)OC PHBAAFDKJNNRNJ-UHFFFAOYSA-N 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical class O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 1
- QAGYKUNXZHXKMR-HKWSIXNMSA-N nelfinavir Chemical compound CC1=C(O)C=CC=C1C(=O)N[C@H]([C@H](O)CN1[C@@H](C[C@@H]2CCCC[C@@H]2C1)C(=O)NC(C)(C)C)CSC1=CC=CC=C1 QAGYKUNXZHXKMR-HKWSIXNMSA-N 0.000 description 1
- 229960000884 nelfinavir Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- QWAXKHKRTORLEM-UGJKXSETSA-N saquinavir Chemical compound C([C@@H]([C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)C=1N=C2C=CC=CC2=CC=1)C1=CC=CC=C1 QWAXKHKRTORLEM-UGJKXSETSA-N 0.000 description 1
- 229960001852 saquinavir Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- UJJDEOLXODWCGK-UHFFFAOYSA-N tert-butyl carbonochloridate Chemical compound CC(C)(C)OC(Cl)=O UJJDEOLXODWCGK-UHFFFAOYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Landscapes
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种合成1,2,3,4-四氢异喹啉衍生物的方法,尤其是一种以苯丙氨酸酯为原料,合成1,2,3,4-四氢异喹啉衍生物的方法。The invention relates to a method for synthesizing 1,2,3,4-tetrahydroisoquinoline derivatives, especially a method for synthesizing 1,2,3,4-tetrahydroisoquinoline derivatives using phenylalanine ester as raw material The method of morphine derivatives.
背景技术Background technique
1,2,3,4-四氢异喹啉衍生物是生物活性分子的合成中间体,该类化合物的结构式如下所示,其中R可以是羟基,烃氧基,伯胺基,仲胺基,苯环可以是含有烃基或烃氧基等取代基。1,2,3,4-Tetrahydroisoquinoline derivatives are synthetic intermediates of biologically active molecules. The structural formula of this type of compound is as follows, where R can be hydroxyl, alkoxy, primary amino, secondary amino , The benzene ring may contain substituents such as hydrocarbyl or hydrocarbyloxy.
1,2,3,4-四氢异喹啉衍生物11,2,3,4-tetrahydroisoquinoline derivatives 1
1,2,3,4-四氢异喹啉衍生物是一类重要的中间体,其中(S)-四氢异喹啉-3-甲酰叔丁胺4(R=NHBu′)经过催化氢化后得到的十氢异喹啉-3-甲酰叔丁胺是抗艾滋病药物沙奎那韦和奈非那韦的关键合成中间体。已经报道的具有工业化应用价值的合成1,2,3,4-四氢异喹啉衍生物的方法主要有两种:1,2,3,4-Tetrahydroisoquinoline derivatives are an important class of intermediates, in which (S)-tetrahydroisoquinoline-3-formyl tert-butylamine 4 (R=NHBu') undergoes catalytic hydrogenation The obtained decahydroisoquinoline-3-formyl tert-butylamine is a key synthetic intermediate of the anti-AIDS drugs saquinavir and nelfinavir. There are mainly two methods for the synthesis of 1,2,3,4-tetrahydroisoquinoline derivatives reported with industrial application value:
(1)(L)-苯丙氨酸2在甲醛和浓盐酸下经过Pictet-Spengler环合生成(S)-四氢异喹啉-3-羧酸3,和光气或者三光气反应生成N-羧酸酐后,再与叔丁胺反应得到(S)-四氢异喹啉-3-甲酰叔丁胺4(见US 6433177;6340760;5587481号专利),合成路线如下:(1) (L)-Phenylalanine 2 undergoes Pictet-Spengler cyclization under formaldehyde and concentrated hydrochloric acid to generate (S)-tetrahydroisoquinoline-3-carboxylic acid 3, which reacts with phosgene or triphosgene to generate N- After the carboxylic anhydride, react with tert-butylamine to obtain (S)-tetrahydroisoquinoline-3-formyl tert-butylamine 4 (see US 6433177; 6340760; No. 5587481 patent), the synthetic route is as follows:
(2)(L)-苯丙氨酸2经过氯甲酸苄酯保护得到N-苄氧酰基苯丙氨酸5,再与氯甲酸叔丁酯反应形成活化酯,活化酯与叔丁胺反应生成酰胺6。酰胺6在二(甲氧基)甲烷在混和酸(浓硫酸和浓醋酸)作用下环合生成N-苄氧甲酰基四氢异喹啉-3-甲酰叔丁胺7,在钯-碳催化下氢解去保护得到(S)-四氢异喹啉-3-甲酰叔丁胺4(见US 5256783号专利),合成路线如下:(2) (L)-Phenylalanine 2 was protected by benzyl chloroformate to obtain N-benzyloxyacylphenylalanine 5, and then reacted with tert-butyl chloroformate to form an activated ester, which reacted with tert-butylamine to form amide 6 . Amide 6 is cyclized in di(methoxy)methane under the action of mixed acid (concentrated sulfuric acid and concentrated acetic acid) to generate N-benzyloxyformyl tetrahydroisoquinoline-3-formyl tert-butylamine 7, under palladium-carbon catalysis Hydrogenolysis deprotection obtains (S)-tetrahydroisoquinoline-3-formyl tert-butylamine 4 (see patent No. US 5256783), and the synthetic route is as follows:
尽管方法1的合成路线是便捷的,但主要的局限性在于合成路线中的Pictet-Spengler环合反应所用到的甲醛和浓盐酸,在反应中产生的副产物α-卤代醚(主要是氯甲基甲醚和双氯甲基甲醚)具有严重的致癌作用。因此,通常限制甲醛和浓盐酸体系在工业生产的使用(ArchEnviron Health,1975,30:61~72)。同时,由于Pictet-Spengler环合反应的剧烈反应条件会产生部分消旋化作用,通常消旋化率达32%左右,这对于需要合成光学纯的1,2,3,4-四氢异喹啉衍生物是不利的。方法2的优点主要在于温和的环合反应条件,避免了环合反应中的消旋化现象,而且采用二甲氧基甲烷/混酸代替甲醛/盐酸体系避免了致癌物质α-卤代醚的生成。但是该反应路线的主要局限性在于需要两次用到氯甲酸酯。氯甲酸酯类化合物无论在生产还是在使用中都存在着对反应设备的腐蚀、环境污染以及安全性等问题。Although the synthetic route of method 1 is convenient, the main limitation is the formaldehyde and concentrated hydrochloric acid used in the Pictet-Spengler ring closure reaction in the synthetic route, and the by-product α-halogenated ether (mainly chlorine Methyl ether and bischloromethyl ether) have serious carcinogenic effects. Therefore, the use of formaldehyde and concentrated hydrochloric acid systems in industrial production is usually limited (ArchEnviron Health, 1975, 30: 61-72). At the same time, due to the severe reaction conditions of the Pictet-Spengler cyclization reaction, partial racemization will occur, usually with a racemization rate of about 32%, which is necessary for the synthesis of optically pure 1,2,3,4-tetrahydroisoquinone Phenyl derivatives are unfavorable. The advantages of method 2 mainly lie in the mild cyclization reaction conditions, avoiding the racemization phenomenon in the cyclization reaction, and using dimethoxymethane/mixed acid instead of formaldehyde/hydrochloric acid system to avoid the formation of carcinogenic α-halogenated ethers . But the main limitation of this reaction scheme is the need to use chloroformate twice. Chloroformic ester compounds have problems such as corrosion to reaction equipment, environmental pollution and safety no matter in production or in use.
发明内容Contents of the invention
本发明的目的在于提供一种以苯丙氨酸酯为原料,采用苄基保护氨基方法,二(甲氧基)甲醚环合条件合成1,2,3,4-四氢异喹啉衍生物的方法。The object of the present invention is to provide a kind of with phenylalanine ester as raw material, adopt benzyl to protect amino method, bis(methoxy) methyl ether ring closure condition synthesizes 1,2,3,4-tetrahydroisoquinoline derivative way of things.
本发明的合成路线如下所示:The synthetic route of the present invention is as follows:
具体反应过程如下:Concrete reaction process is as follows:
1)苯丙氨酸酯8和苯甲醛在酸的催化下缩合生成N-亚苄基苯丙氨酸酯,再经过催化氢化得到N-苄基苯丙氨酸酯9。缩合反应溶剂可以采用卤代烃,如:二氯甲烷,三氯甲烷或1,2-二氯乙烷等。反应温度为30~55℃。酸催化剂包括无机酸或有机酸,如盐酸,硫酸,乙酸或丙酸等。氢化还原反应的溶剂一般采用低级醇或低级醇与醚的混合溶剂,低级醇指甲醇,乙醇,丙醇或异丙醇等,醚主要是乙醚或异丙醚等。催化氢化的催化剂为兰尼镍(Raney-Ni),催化氢化的反应温度在10~50℃,氢气压力为5~20bar。1) Phenylalanine 8 and benzaldehyde are condensed under the catalysis of acid to generate N-benzylidene phenylalanine, and then undergo catalytic hydrogenation to obtain N-benzyl phenylalanine 9. The condensation reaction solvent can be halogenated hydrocarbon, such as: dichloromethane, trichloromethane or 1,2-dichloroethane and the like. The reaction temperature is 30-55°C. Acid catalysts include inorganic acids or organic acids, such as hydrochloric acid, sulfuric acid, acetic acid or propionic acid and the like. The solvent for the hydrogenation reduction reaction generally adopts lower alcohol or a mixed solvent of lower alcohol and ether. The lower alcohol refers to methanol, ethanol, propanol or isopropanol, etc., and the ether is mainly diethyl ether or isopropyl ether. The catalytic hydrogenation catalyst is Raney-Ni, the reaction temperature of the catalytic hydrogenation is 10-50° C., and the hydrogen pressure is 5-20 bar.
2)N-苄基苯丙氨酸酯的碱催化水解得到N-苄基苯丙氨酸10。水解催化剂采用无机碱,如氢氧化钠,氢氧化钾或氢氧化锂等。反应溶剂为低级醇或低级醇与水的混合溶剂,低级醇指甲醇,乙醇,丙醇或异丙醇等,反应温度一般在50~100℃。2) Base-catalyzed hydrolysis of N-benzylphenylalanine ester affords N-benzylphenylalanine 10. The hydrolysis catalyst adopts inorganic base, such as sodium hydroxide, potassium hydroxide or lithium hydroxide etc. The reaction solvent is lower alcohol or a mixed solvent of lower alcohol and water. Lower alcohol refers to methanol, ethanol, propanol or isopropanol, etc., and the reaction temperature is generally 50-100°C.
3)N-苄基苯丙氨酸10在无氧无水的条件下和三光气反应制成N-羧酸酐,然后在低温下将N-羧酸酐的溶液缓慢滴加到叔丁胺中进行酰化反应,生成N-苄基苯丙氨酰叔丁胺11。N-羧酸酐反应在醚类溶剂中进行,如二氧六环。反应温度在60~120℃。酰化反应溶剂为卤代烃,如:二氯甲烷,三氯甲烷,1,2-二氯乙烷等,反应温度在-75~0℃。3) N-benzylphenylalanine 10 reacts with triphosgene under anaerobic and anhydrous conditions to produce N-carboxylic anhydride, and then slowly adds the solution of N-carboxylic anhydride to tert-butylamine at low temperature for acylation The reaction produces N-benzylphenylalanyl tert-butylamine 11. The N-carboxylic acid anhydride reaction is carried out in an ether solvent, such as dioxane. The reaction temperature is between 60°C and 120°C. The acylation reaction solvent is a halogenated hydrocarbon, such as dichloromethane, trichloromethane, 1,2-dichloroethane, etc., and the reaction temperature is -75-0°C.
4)N-苄基苯丙氨酰叔丁胺11与二甲氧基甲烷在酸催化下环合生成N-苄基四氢异喹啉-3-甲酰叔丁胺12。催化剂可以是无机酸,或无机酸与有机酸的混酸,或三氟化硼乙醚。反应溶剂为卤代烃,如:二氯甲烷,三氯甲烷,1,2-二氯乙烷等。反应温度为30~60℃。4) N-benzylphenylalanyl tert-butylamine 11 was cyclized with dimethoxymethane under acid catalysis to generate N-benzyltetrahydroisoquinoline-3-formyl tert-butylamine 12. The catalyst can be an inorganic acid, or a mixed acid of an inorganic acid and an organic acid, or boron trifluoride ether. The reaction solvent is a halogenated hydrocarbon, such as dichloromethane, chloroform, 1,2-dichloroethane and the like. The reaction temperature is 30-60°C.
5)N-苄基四氢异喹啉-3-甲酰叔丁胺12催化下氢解脱苄基得到四氢异喹啉-3-甲酰叔丁胺4。氢解反应催化剂为钯-碳,可采用氢气/钯-碳或甲酸铵/钯-碳氢化体系。反应溶剂为低级醇,如甲醇,乙醇或丙醇等。反应温度为50~100℃。5) N-benzyltetrahydroisoquinoline-3-formyl tert-butylamine 12 is catalyzed by hydrogenolysis and debenzylation to obtain tetrahydroisoquinoline-3-formyl tert-butylamine 4. The hydrogenolysis reaction catalyst is palladium-carbon, and hydrogen/palladium-carbon or ammonium formate/palladium-carbon hydrogenation system can be used. The reaction solvent is a lower alcohol, such as methanol, ethanol or propanol. The reaction temperature is 50-100°C.
本发明的合成路线的特点在于用一种新的合成方法制备1,2,3,4-四氢异喹啉衍生物。以苯丙氨酸酯为原料,采用苄基保护氨基方法,免除了氯甲酸酯的使用。环合反应采用二(甲氧基)甲醚环合条件,避免采用甲醛/浓盐酸生成致癌物质α-卤代醚的隐患。所用的原料易得,价格低廉,适合于工业化生产的应用。The synthetic route of the present invention is characterized in that a novel synthetic method is used to prepare 1,2,3,4-tetrahydroisoquinoline derivatives. Using phenylalanine ester as raw material, the method of protecting amino group with benzyl group avoids the use of chloroformate. The cyclization reaction adopts bis(methoxy)methyl ether cyclization conditions to avoid the hidden danger of using formaldehyde/concentrated hydrochloric acid to generate carcinogenic α-halogenated ethers. The raw materials used are easy to obtain and low in price, and are suitable for industrial production.
具体实施方式Detailed ways
下面通过实施例对本发明作进一步的说明。Below by embodiment the present invention will be further described.
实施例1:Example 1:
步骤1.(L)-N-亚苄基苯丙氨酸甲酯 (L)-苯丙氨酸甲酯(1.526g,8.52mmol)中加入二氯甲烷15ml,无水硫酸镁0.88g及4滴浓硫酸。室温下搅拌滴加苯甲醛0.58ml。50℃加热回流24h,过滤,减压浓缩得到淡黄色油状物。加入无水乙醚20ml。依次用饱和氯化钠溶液液(10ml×2)、水(10ml×2)洗涤。无水硫酸镁干燥,过滤,减压浓缩得到淡黄色液体1.797g。产率79%。Step 1. (L)-N-benzylidene phenylalanine methyl ester (L)-phenylalanine methyl ester (1.526g, 8.52mmol) was added dichloromethane 15ml, anhydrous magnesium sulfate 0.88g and 4 Drop concentrated sulfuric acid. 0.58 ml of benzaldehyde was added dropwise with stirring at room temperature. Heated to reflux at 50°C for 24h, filtered, and concentrated under reduced pressure to obtain a pale yellow oil. Add 20ml of anhydrous diethyl ether. Wash with saturated sodium chloride solution (10ml×2) and water (10ml×2) successively. Dry over anhydrous magnesium sulfate, filter, and concentrate under reduced pressure to obtain 1.797 g of a light yellow liquid. Yield 79%.
1H-NMR(CDCl3,500MHz)δ:8.11(s,1H,N=CH),7.50~7.10(m,10H,2×Ph-H),4.35(m,1H,BnCH),3.70(m,3H,OCH3),3.40(m,1H,PhCH2),3.20(m,1H,PhCH2)。 1 H-NMR (CDCl 3 , 500MHz) δ: 8.11(s, 1H, N=CH), 7.50~7.10(m, 10H, 2×Ph-H), 4.35(m, 1H, BnCH), 3.70(m , 3H, OCH 3 ), 3.40 (m, 1H, PhCH 2 ), 3.20 (m, 1H, PhCH 2 ).
步骤2.(L)-N-苄基苯丙氨酸甲酯 高压釜反应器中加入(L)-N-亚苄基苯丙氨酸甲酯(3.204g,12.0mmol),无水乙醇25ml及Raney-Ni 0.35g。在25℃通氢气,保持氢压在7bar下,搅拌反应7h,过滤,减压浓缩得到黄色液体3.227g。产率100%。Step 2. (L)-N-benzylphenylalanine methyl ester Add (L)-N-benzylidene phenylalanine methyl ester (3.204g, 12.0mmol) and 25ml of absolute ethanol to the autoclave reactor and Raney-Ni 0.35g. Pass hydrogen at 25°C, keep the hydrogen pressure at 7bar, stir the reaction for 7h, filter, and concentrate under reduced pressure to obtain 3.227g of yellow liquid. Yield 100%.
1H-NMR(CDCl3,500MHz)δ:7.25~7.15(m,10H,2×Ph-H),3.80(d,2H,CH2N),3.74(s,1H,CHN),3.64(s,3H,OCH3),2.95(dd,J=1.53×4.91Hz,2H,CCH2),1.85(s,1H,NHBn)。 1 H-NMR (CDCl 3 , 500MHz) δ: 7.25~7.15 (m, 10H, 2×Ph-H), 3.80 (d, 2H, CH 2 N), 3.74 (s, 1H, CHN), 3.64 (s , 3H, OCH 3 ), 2.95 (dd, J=1.53×4.91 Hz, 2H, CCH 2 ), 1.85 (s, 1H, NHBn).
步骤3.(L)-N-苄基苯丙氨酸 (L)-N-苄基苯丙氨酸甲酯(10.95g,40.71mmol)中加入25ml甲醇,搅拌下滴加3mol/L氢氧化钠27ml。于68℃加热回流9h。减压浓缩。加入水30ml,用乙酸乙酯15ml萃取。水层用10%盐酸调pH至5~6之间,出现大量白色固体,过滤。白色固体用少量水、无水甲醇洗涤。40℃真空干燥5h,得到白色固体9.19g。产率88.5%。m.p.185.5~186.5℃。Step 3. Add 25ml methanol to (L)-N-benzylphenylalanine (L)-N-benzylphenylalanine methyl ester (10.95g, 40.71mmol), and add 3mol/L hydrogen dropwise under stirring Sodium 27ml. Heated to reflux at 68°C for 9h. Concentrate under reduced pressure. 30 ml of water was added, followed by extraction with 15 ml of ethyl acetate. The pH of the aqueous layer was adjusted to 5-6 with 10% hydrochloric acid, and a large amount of white solid appeared, which was filtered. The white solid was washed with a small amount of water and anhydrous methanol. Vacuum drying at 40°C for 5 hours gave 9.19 g of a white solid. Yield 88.5%. m.p.185.5~186.5℃.
MS(ESI):256(MH+,100)。MS (ESI): 256 (MH + , 100).
步骤4.(L)-N-苄基苯丙氨酰叔丁胺 (L)-N-苄基苯丙氨酸(1.76g,6.90mmol)中加入20ml无水二氧六环,搅拌下滴加三光气的二氧六环溶液(三光气:1.6g,5.4mmol+二氧六环:6ml),约10min加完。于110℃加热回流1h,隔15min通一次氮气。75℃减压浓缩。加入甲苯(13ml×2),搅拌5min后在55℃下减压浓缩。加入二氯甲烷17ml。将得到的N-羧酸酐溶液滴加到已冷却到-75℃的叔丁胺1.64ml中,搅拌2.5h后,缓慢升至室温。减压浓缩,加入二氯甲烷25ml。过滤除去不溶物。加入水20ml,滴加10%盐酸调pH约5。分出有机层。水层用3mol/L氢氧化钠溶液调pH至10左右,加入乙酸乙酯20ml萃取。水层用乙酸乙酯(10ml×2)萃取,合并有机相。有机层用无水硫酸钠干燥,过滤,减压浓缩得到黄色液体1.579g。产率73.8%。Step 4. Add 20ml of anhydrous dioxane to (L)-N-benzylphenylalanyl tert-butylamine (L)-N-benzylphenylalanine (1.76g, 6.90mmol), and add Sanko dropwise under stirring Gas dioxane solution (triphosgene: 1.6g, 5.4mmol+dioxane: 6ml), the addition was completed in about 10 minutes. Heat to reflux at 110°C for 1 hour, and pass nitrogen once every 15 minutes. Concentrate under reduced pressure at 75°C. Toluene (13ml×2) was added, stirred for 5min and then concentrated under reduced pressure at 55°C. 17 ml of dichloromethane was added. The obtained N-carboxylic acid anhydride solution was added dropwise to 1.64ml of tert-butylamine cooled to -75°C, stirred for 2.5h, and then slowly raised to room temperature. Concentrate under reduced pressure, and add 25 ml of dichloromethane. Insoluble materials were removed by filtration. 20ml of water was added, and 10% hydrochloric acid was added dropwise to adjust the pH to about 5. Separate the organic layer. The pH of the aqueous layer was adjusted to about 10 with 3mol/L sodium hydroxide solution, and 20ml of ethyl acetate was added for extraction. The aqueous layer was extracted with ethyl acetate (10ml×2), and the organic phases were combined. The organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to obtain 1.579 g of a yellow liquid. Yield 73.8%.
1H-NMR(CDCl3,500MHz)δ:7.4~7.15(m,10H,2×Ph-H),4.13(m,1H,CHN),3.60(s,2H,CH2N),3.20(m,1H,CH2C),2.75(m,1H,CH2C),2.00(s,1H,NHBn),1.33~1.25(m,9H,3×CH3)。 1 H-NMR (CDCl 3 , 500MHz) δ: 7.4~7.15 (m, 10H, 2×Ph-H), 4.13 (m, 1H, CHN), 3.60 (s, 2H, CH 2 N), 3.20 (m , 1H, CH 2 C), 2.75 (m, 1H, CH 2 C), 2.00 (s, 1H, NHBn), 1.33-1.25 (m, 9H, 3×CH 3 ).
步骤5.(S)-N-苄基四氢异喹啉-3-甲酰叔丁胺 (L)-N-苄基苯丙氨酰叔丁胺(1.181g,3.81mmol)中加入二氯甲烷40ml,搅拌下滴加三氟化硼的乙醚溶液(40%)3.9ml。搅拌下滴加二甲氧基甲烷(0.7ml,7.92mmol)。在40~45℃加热回流48h。加入水9ml。滴加氨水(27%)3.0ml调pH约8。分出有机层。水层用二氯甲烷(15ml×2)萃取,合并有机层。用饱和氯化钠溶液洗涤至中性。无水硫酸钠干燥,过滤,减压浓缩。用正己烷5ml重结晶,得到白色片状晶体0.756g。产率61.6%。Step 5. Add 40ml of dichloromethane to (S)-N-benzyltetrahydroisoquinoline-3-formyl tert-butylamine (L)-N-benzylphenylalanyl tert-butylamine (1.181g, 3.81mmol) and stir 3.9 ml of a diethyl ether solution (40%) of boron trifluoride was added dropwise. Dimethoxymethane (0.7ml, 7.92mmol) was added dropwise with stirring. Heat to reflux at 40-45°C for 48h. Add water 9ml. Add 3.0 ml of ammonia water (27%) dropwise to adjust the pH to about 8. Separate the organic layer. The aqueous layer was extracted with dichloromethane (15ml×2), and the organic layers were combined. Wash with saturated sodium chloride solution until neutral. Dry over anhydrous sodium sulfate, filter, and concentrate under reduced pressure. Recrystallized with 5 ml of n-hexane to obtain 0.756 g of white flaky crystals. Yield 61.6%.
m.p.107.5~108℃。[α]589 20=-6.919°(c=1.03,MeOH)。mp107.5~108℃. [α] 589 20 = -6.919° (c = 1.03, MeOH).
MS(ESI):323(MH+,100)。MS (ESI): 323 (MH + , 100).
1H-NMR(CDCl3,500MHz)δ:7.35~7.25(m,9H,2×Ph-H),4.10(d,J=5.22Hz,1H,CHC=O),3.78(m,1H,CH2N),3.74(m,1H,CH2N),3.40(m,1H,CH2N),3.36(m,1H,CH2N),3.12(m,1H,CH2CC=O),2.95(m,1H,CH2CC=O),2.00(s,1H,NHBn),1.30(s,9H,3×CH3)。 1 H-NMR (CDCl 3 , 500MHz) δ: 7.35~7.25 (m, 9H, 2×Ph-H), 4.10 (d, J=5.22Hz, 1H, CHC=O), 3.78 (m, 1H, CH 2N ), 3.74(m, 1H, CH2N ), 3.40(m, 1H, CH2N ), 3.36(m, 1H, CH2N), 3.12(m, 1H , CH2CC =O), 2.95 (m, 1H, CH2CC =O), 2.00 (s, 1H, NHBn), 1.30 (s, 9H, 3 x CH3 ).
步骤6.(S)-四氢异喹啉-3-甲酰叔丁胺 在(S)-N-苄基四氢异喹啉-3-甲酰叔丁胺的甲醇溶液[(S)-N-苄基四氢异喹啉-3-甲酰叔丁胺:1.66g,5.15mmol+甲醇:25ml]中加入甲酸铵的甲醇溶液(甲酸铵:0.98g,15.5mmol+甲醇:10ml)及钯碳0.4g。在75℃加热回流7h,过滤,减压浓缩。依次加入乙酸乙酯20ml、水5ml。分出有机层。减压浓缩。加入正己烷8ml重结晶,得到白色固体0.991g。产率83.0%。Step 6. (S)-Tetrahydroisoquinoline-3-formyl tert-butylamine in methanol solution of (S)-N-benzyltetrahydroisoquinoline-3-formyl tert-butylamine [(S)-N-benzyl Tetrahydroisoquinoline-3-formyl tert-butylamine: 1.66g, 5.15mmol+methanol: 25ml] was added methanol solution of ammonium formate (ammonium formate: 0.98g, 15.5mmol+methanol: 10ml) and palladium carbon 0.4g. Heated to reflux at 75°C for 7h, filtered and concentrated under reduced pressure. 20 ml of ethyl acetate and 5 ml of water were successively added. Separate the organic layer. Concentrate under reduced pressure. 8 ml of n-hexane was added for recrystallization to obtain 0.991 g of a white solid. Yield 83.0%.
m.p.94.5~95℃。[α]589 20=-104.3°(c=1.03,MeOH)。mp94.5~95℃. [α] 589 20 = -104.3° (c = 1.03, MeOH).
MS(ESI):233(MH+,100)。MS (ESI): 233 (MH + , 100).
1H-NMR(CDCl3,500MHz)δ:7.20~7.00(m,4H,Ph-H),4.0(m,2H,CH2N),3.45(m,1H,CHC=O),3.20(m,1H,PhCH2C),2.80(m,1H,PhCH2C),1.65(s,1H,NHC),1.40(s,9H,3×CH3)。 1 H-NMR (CDCl 3 , 500MHz) δ: 7.20~7.00 (m, 4H, Ph-H), 4.0 (m, 2H, CH 2 N), 3.45 (m, 1H, CHC=O), 3.20 (m , 1H, PhCH 2 C), 2.80 (m, 1H, PhCH 2 C), 1.65 (s, 1H, NHC), 1.40 (s, 9H, 3×CH 3 ).
实施例2:Example 2:
步骤1.(L)-N-亚苄基苯丙氨酸甲酯 (L)-苯丙氨酸甲酯(1.513g,8.44mmol)中加入二氯甲烷15ml,无水硫酸镁0.88g及10滴乙酸。室温下搅拌滴加苯甲醛0.58ml。于50℃加热回流24h。过滤。减压浓缩得到淡黄色油状物。加入无水乙醚20ml。依次用饱和氯化钠溶液(10ml×2)、水(10ml×2)洗涤。无水硫酸镁干燥,过滤,减压浓缩得到淡黄色液体1.683g。产率75%。Step 1. (L)-N-benzylidene phenylalanine methyl ester (L)-phenylalanine methyl ester (1.513g, 8.44mmol) was added dichloromethane 15ml, anhydrous magnesium sulfate 0.88g and 10 Drops of acetic acid. 0.58 ml of benzaldehyde was added dropwise with stirring at room temperature. Heated to reflux at 50°C for 24h. filter. Concentration under reduced pressure gave a pale yellow oil. Add 20ml of anhydrous diethyl ether. Wash with saturated sodium chloride solution (10ml×2) and water (10ml×2) successively. Dry over anhydrous magnesium sulfate, filter, and concentrate under reduced pressure to obtain 1.683 g of a light yellow liquid. Yield 75%.
步骤2.(L)-N-苄基苯丙氨酸甲酯 高压釜反应器中加入(L)-N-亚苄基苯丙氨酸甲酯(1.600g,6.0mmol),无水乙醇12ml+异丙醚6ml及Raney-Ni 0.35g。在25℃通氢气,保持氢压在7bar下,搅拌反应7h,过滤,减压浓缩得到黄色液体1.613g。产率100%。Step 2. (L)-N-benzylphenylalanine methyl ester Add (L)-N-benzylidene phenylalanine methyl ester (1.600g, 6.0mmol) and 12ml of absolute ethanol to the autoclave reactor Isopropyl ether 6ml and Raney-Ni 0.35g. Pass hydrogen at 25°C, keep the hydrogen pressure at 7bar, stir the reaction for 7h, filter, and concentrate under reduced pressure to obtain 1.613g of yellow liquid. Yield 100%.
步骤3.(L)-N-苄基苯丙氨酸 同实施例1。Step 3.(L)-N-benzylphenylalanine Same as Example 1.
步骤4.(L)-N-苄基苯丙氨酰叔丁胺 同实施例1。Step 4.(L)-N-benzylphenylalanyl tert-butylamine Same as Example 1.
步骤5.(S)-N-苄基四氢异喹啉-3-甲酰叔丁胺 (L)-N-苄基苯丙氨酰叔丁胺(1.178g,3.80mmol)中加入二氯甲烷40ml,搅拌下滴加硫酸/乙酸(1/2体积比)1.2ml。搅拌下滴加二甲氧基甲烷(0.7ml,7.92mmol)。在40~45℃加热回流48h。加入水9ml。滴加氨水(27%)5.0ml调pH约8。分出有机层。水层用二氯甲烷(15ml×2)萃取,合并有机层。用饱和氯化钠溶液洗涤至中性。无水硫酸钠干燥,过滤,减压浓缩。用正己烷5ml重结晶,得到白色片状晶体0.653g。产率53.3%。Step 5. Add 40ml of dichloromethane to (S)-N-benzyltetrahydroisoquinoline-3-formyl tert-butylamine (L)-N-benzylphenylalanyl tert-butylamine (1.178g, 3.80mmol) and stir 1.2 ml of sulfuric acid/acetic acid (1/2 volume ratio) was added dropwise. Dimethoxymethane (0.7ml, 7.92mmol) was added dropwise with stirring. Heat to reflux at 40-45°C for 48h. Add water 9ml. Add 5.0 ml of ammonia water (27%) dropwise to adjust the pH to about 8. Separate the organic layer. The aqueous layer was extracted with dichloromethane (15ml×2), and the organic layers were combined. Wash with saturated sodium chloride solution until neutral. Dry over anhydrous sodium sulfate, filter, and concentrate under reduced pressure. Recrystallized with 5 ml of n-hexane to obtain 0.653 g of white flaky crystals. Yield 53.3%.
步骤6.(S)-四氢异喹啉-3-甲酰叔丁胺 在(S)-N-苄基四氢异喹啉-3-甲酰叔丁胺的甲醇溶液[(S)-N-苄基四氢异喹啉-3-甲酰叔丁胺:1.68g,5.22mmol+甲醇:25ml]中加入钯碳0.4g。通氢气,在50℃和10bar氢压下搅拌反应7h,过滤,减压浓缩。依次加入乙酸乙酯20ml、水5ml。分出有机层。减压浓缩。加入正己烷8ml重结晶,得到白色固体0.989g。产率81.7%。Step 6. (S)-Tetrahydroisoquinoline-3-formyl tert-butylamine in methanol solution of (S)-N-benzyltetrahydroisoquinoline-3-formyl tert-butylamine [(S)-N-benzyl Tetrahydroisoquinoline-3-formyl tert-butylamine: 1.68g, 5.22mmol+methanol: 25ml] was added 0.4g of palladium carbon. Pass through hydrogen, stir the reaction at 50°C and 10bar hydrogen pressure for 7h, filter and concentrate under reduced pressure. 20 ml of ethyl acetate and 5 ml of water were successively added. Separate the organic layer. Concentrate under reduced pressure. 8 ml of n-hexane was added for recrystallization to obtain 0.989 g of a white solid. Yield 81.7%.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100320171A CN1300115C (en) | 2004-03-26 | 2004-03-26 | Method for synthesizing 1,2,3,4 ramification of tetrahydro-isoquinoline |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100320171A CN1300115C (en) | 2004-03-26 | 2004-03-26 | Method for synthesizing 1,2,3,4 ramification of tetrahydro-isoquinoline |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1562974A true CN1562974A (en) | 2005-01-12 |
CN1300115C CN1300115C (en) | 2007-02-14 |
Family
ID=34481277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100320171A Expired - Fee Related CN1300115C (en) | 2004-03-26 | 2004-03-26 | Method for synthesizing 1,2,3,4 ramification of tetrahydro-isoquinoline |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1300115C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008043269A1 (en) * | 2006-10-09 | 2008-04-17 | Shanghai Institute Of Pharmaceutical Industry | Preparation method for 1-(3-methyloxybenzene)ethylamine with optical activity |
CN100503571C (en) * | 2006-07-12 | 2009-06-24 | 中国药科大学 | Tetrahydroisoquinoline derivatives, preparation method and medical use thereof |
CN100586925C (en) * | 2005-09-30 | 2010-02-03 | 上海医药工业研究院 | Synthesis method of pharmaceutically acceptable salt of 4-methoxy-α-methyl-phenethylamine |
CN104710356A (en) * | 2015-04-08 | 2015-06-17 | 张伟 | Preparation method of 1,2,3,4-tetrahydroisoquinoline |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5256783A (en) * | 1991-09-18 | 1993-10-26 | Hoffmann-La Roche Inc. | Method for producing 2-isoquinoline compounds |
US5587481A (en) * | 1996-02-20 | 1996-12-24 | The Monsanto Company | Preparation of (S)-decahydroisoquinoline-3-carboxylic acid t-butylamide |
AU4721897A (en) * | 1996-10-25 | 1998-05-22 | Tanabe Seiyaku Co., Ltd. | Tetrahydroisoquinoline derivatives |
IT1301825B1 (en) * | 1998-06-26 | 2000-07-07 | Archimica Spa | PROCEDURE FOR THE PREPARATION OF (S) -N-TERBUTYL-1,2,3,4-TETRAIDROISOCHINOLIN-3-CARBOXYAMIDE. |
IT1313682B1 (en) * | 1999-11-25 | 2002-09-09 | Archimica Spa | PROCEDURE FOR THE PREPARATION OF (S) -N-TERBUTYL-1,2,3,4-TETRAIDROISOCHINOLIN-3-CARBOXYAMIDE. |
HUP0203431A3 (en) * | 1999-12-03 | 2003-11-28 | Kyoto Pharma Ind | Novel heterocyclic compounds and salts thereof and pharmaceutical compositions containing and use of the same |
-
2004
- 2004-03-26 CN CNB2004100320171A patent/CN1300115C/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100586925C (en) * | 2005-09-30 | 2010-02-03 | 上海医药工业研究院 | Synthesis method of pharmaceutically acceptable salt of 4-methoxy-α-methyl-phenethylamine |
CN100503571C (en) * | 2006-07-12 | 2009-06-24 | 中国药科大学 | Tetrahydroisoquinoline derivatives, preparation method and medical use thereof |
WO2008043269A1 (en) * | 2006-10-09 | 2008-04-17 | Shanghai Institute Of Pharmaceutical Industry | Preparation method for 1-(3-methyloxybenzene)ethylamine with optical activity |
CN104710356A (en) * | 2015-04-08 | 2015-06-17 | 张伟 | Preparation method of 1,2,3,4-tetrahydroisoquinoline |
Also Published As
Publication number | Publication date |
---|---|
CN1300115C (en) | 2007-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11952341B2 (en) | Method of preparing high chiral purity lactam intermediate and brivaracetam | |
JPWO2003097632A1 (en) | Propanolamine derivative, method for producing 3-N-methylamino-1- (2-thienyl) -1-propanol, and method for producing propanolamine derivative | |
US4851537A (en) | Process for preparing N-acyltetrahydroisoquinoline | |
US20080306292A1 (en) | Synthesis of (S)-(+)-3-(aminomethyl)-5-methyl hexanoic acid | |
JP2818763B2 (en) | O-alkylated compounds of N- (hydroxy) aralkylphenylethanolamines | |
EP2268827B1 (en) | Process of making optically pure melphalan | |
CN1300115C (en) | Method for synthesizing 1,2,3,4 ramification of tetrahydro-isoquinoline | |
CA1231719A (en) | Synthesis of phenyl alanine derivatives | |
CN1187328C (en) | Method for synthesizing indigo from N-substituted glycine or glycine ester | |
FI61880C (en) | EXAMINATION OF N-ARYL SULPHONYL-N '- (3-AZABICYCLOALKYL) -URINAEMNEN | |
AU617197B2 (en) | Process for the synthesis of optically active aminoacids | |
KR100743617B1 (en) | Process for the preparation of chiral 3-hydroxy pyrrolidine compound and derivatives thereof having high optical purity | |
EP1864973A1 (en) | Process for the preparation of perindopril and salts thereof | |
WO2007024113A1 (en) | Process for the preparation of chiral 3-hydroxy pyrrolidine compound and derivatives thereof having high optical purity | |
EP2102145A1 (en) | Process for the preparation and isolation of the individual stereoisomers of 1-amino, 3-substituted phenylcyclopentane carboxylates | |
JP3175339B2 (en) | Optically active amine compound, its production method, its intermediate and its use | |
RU2363695C2 (en) | Method for preparation of perindopril with usage of tetramethyl-uronium salts as reagent of coupling reaction | |
US4029647A (en) | Synthesis of biotin | |
EP1724260B1 (en) | Process for the synthesis of (2S, 3aR, 7aS)octahydroindole-2-carboxylic acid and its conversion to trandolapril | |
US6462234B2 (en) | Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2, 3-dihydro-1H-indene-5-carboxamide | |
US6313315B1 (en) | Methods for producing N-protected-azetidine-2-carboxylic acids | |
JP2829306B2 (en) | 2-amino-7-hydroxytetralin ether derivative | |
CN100341850C (en) | Salts of demethyl phencynonate isomer and N-para-methyl-phenyl-sulfuryl glutamic acid optical isomer and their preparing method and use | |
KR870001084B1 (en) | Method for preparing aminobenzylamine | |
FI66590C (en) | PROCEDURE FOR FRAMSTATION OF AV 5'-ALKANOYLAMINO-2 '- (2-HYDROXI-3-ISOPROPYLAMINOPROPOXY) -ACETOFENONE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070214 Termination date: 20100326 |